Approval projections for therapeutic mAbs
Includes sales potential in 2008 (in billions)
SOURCES: PROTEIN THERAPEUTIC SUCCESS RATES INCREASE WITH BIOTECH ADVANCES, TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT, BOSTON, MARCH 2005, AND MONOCLONAL ANTIBODY THERAPIES: EVOLVING INTO A $30 BILLION MARKET, DATAMONITOR, LONDON, APRIL 2005